Eli Lilly, Sanford-Burnham Medical Research Institute deal

Eli Lilly and Sanford-Burnham partnered to discover and develop immune checkpoint modulators to treat autoimmune diseases, including lupus, Sjogren’s syndrome and inflammatory bowel disease (IBD). The...